ARCHIVES

Tyrosine Kinase Inhibitor Encoraging For NSCLC

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Alternative to Animal Use In Research Outlined By OTA

February 21, 1986

NCI Lists Five Comparative Effectiveness Projects For Stimulus Funds

February 6, 2009

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

Medenica’s Privileges Extended; Patient sue Hilton Head Physicians

June 4, 1993